You are here

Genentech

Ex-Genentech principal scientist, husband plead guilty in trade secrets case

Bizjournals

Thu, 07/8/21 - 11:43 pm

Novartis says it overpaid Roche's Genentech nearly $210 million in a licensing deal—and it wants its money back

Fierce Pharma

Mon, 06/28/21 - 06:53 pm

Roche Scores Wins in AMD & COVID-19 in Big Week

BioSpace

Sun, 06/27/21 - 12:02 am

wet age-related macular degeneration

Roche's Genentech launches new alliance aimed at achieving greater diversity in cancer trials

Fierce Biotech

Thu, 06/24/21 - 11:02 am

clinical trials

clinical trial diversity

Advancing Inclusive Research Site Alliance

A 'springboard' to the future: Genentech, Sanofi and Alnylam execs sound off on pharma's evolving back-to-work plans

Fierce Pharma

Wed, 05/26/21 - 12:05 am

human resources

Roche's virtual gala raises multiple sclerosis awareness with celebrities—and personal connections

Fierce Pharma

Sun, 04/25/21 - 01:46 pm

pharma marketing

multiple sclerosis

Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche

Pharmaforum

Thu, 04/15/21 - 10:02 am

Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair

BioSpace

Tue, 04/13/21 - 10:03 pm

Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers

Fierce Pharma

Thu, 04/1/21 - 11:37 pm

Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll

Fierce Pharma

Thu, 03/18/21 - 11:01 am

Horizon Therapeutics

employee satisfaction

Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom

Endpoints

Mon, 03/15/21 - 10:50 am

GenMark Diagnostics

FDA Approves First Biologic for Rare, Debilitating Lung Disease

BioSpace

Sun, 03/7/21 - 01:35 pm

Genentech teams with academics for 10-year neuroscience R&D push

Fierce Biotech

Sun, 02/28/21 - 10:12 pm

Genentech Could Regain the Blindness-Related Disease Market with New Treatment

BioSpace

Sat, 02/13/21 - 11:01 pm

clinical trials

age-related macular degeneration

Why ipatasertib is not the Akt Astra wants to follow

EP Vantage

Thu, 02/4/21 - 10:39 am

triple negative breast cancer

Roche and Genentech's latest AI collaborator raises $25M Series A to reinvent one of the oldest cancer targets

Endpoints

Wed, 02/3/21 - 10:50 am

artificial intelligence

machine learning

JPM Week: Genentech CEO says partnerships, speedier trials among pandemic's 'silver linings'

Fierce Pharma

Mon, 01/11/21 - 07:03 pm

Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling

Fierce Biotech

Mon, 01/11/21 - 10:30 am

Atalanta Therapeutics

neurodegenerative disease

Genentech Launches $1B+ RNA Collaboration with Ribometrix

Genetic Engineering News

Wed, 01/6/21 - 11:27 pm

small molecule drugs

Genentech pays Relay $75M for cancer drug, plans KRAS combo

Fierce Biotech

Mon, 12/14/20 - 11:07 am

Relay Therapeutics

KRAS inhibitors

Pages